Pre-existing stem cell heterogeneity dictates clonal responses to the acquisition of leukemic driver mutations.

Summary: Why do cancers behave so differently in different patients, even when they share the exact same genetic mutations? Scientists have long suspected that the specific "personality" of the original cell matters just as much as the mutation itself. To prove this, researchers developed a new tracking tool called STRACK. This technology allowed them to tag and watch individual blood stem cells in mice before and after they acquired leukemia-causing mutations.

They discovered something surprising: "weak" stem cells, which are usually naturally replaced by stronger ones, suddenly gain superpowers when they acquire these mutations. Specifically, a mutation called Npm1c caused these cells to reverse their aging process, becoming more primitive and aggressive. This study confirms that a cell’s personal history dictates its future cancer behavior, offering new clues for stopping leukemia at its root.